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Abstract
Background: Artificial intelligence (AI) and machine learning (ML) are interwoven into our everyday lives and have
grown enormously in some major fields in medicine including cardiology and radiology. While these specialties
have quickly embraced AI and ML, orthopedic surgery has been slower to do so. Fortunately, there has been a
recent surge in new research emphasizing the need for a systematic review. The primary objective of this
systematic review will be to provide an update on the advances of AI and ML in the field of orthopedic surgery.
The secondary objectives will be to evaluate the applications of AI and ML in providing a clinical diagnosis and
predicting post-operative outcomes and complications in orthopedic surgery.
Methods: A systematic search will be conducted in PubMed, ScienceDirect, and Google Scholar databases for
articles written in English, Italian, French, Spanish, and Portuguese language articles published up to September
2020. References will be screened and assessed for eligibility by at least two independent reviewers as per PRISMA
guidelines. Studies must apply to orthopedic interventions and acute and chronic orthopedic musculoskeletal
injuries to be considered eligible. Studies will be excluded if they are animal studies and do not relate to
orthopedic interventions or if no clinical data were produced. Gold standard processes and practices to obtain a
clinical diagnosis and predict post-operative outcomes shall be compared with and without the use of ML
algorithms. Any case reports and other primary studies assessing the prediction rate of post-operative outcomes or
the ability to identify a diagnosis in orthopedic surgery will be included. Systematic reviews or literature reviews will
be examined to identify further studies for inclusion, and the results of meta-analyses will not be included in the
analysis.
Discussion: Our findings will evaluate the advances of AI and ML in the field of orthopedic surgery. We expect to
find a large quantity of uncontrolled studies and a smaller subset of articles describing actual applications and
outcomes for clinical care. Cohort studies and large randomized control trial will likely be needed.
Trial registration: The protocol will be registered on PROSPERO international prospective register of systematic
reviews prior to commencement.
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Background
Artificial intelligence (AI) and machine learning (ML)
are interwoven in our everyday lives: from the way our
email inbox is organized to the algorithms that dictate
our Netflix preferences. In comparison, the adoption of
ML in the medical field has been relatively slower, but
there has been a recent surge in growth. AI and ML
have been applied in various fields of medicine such as
mental health, cardiology, dermatology, and radiology,
where they have seen the greatest use [1, 2]. AI and ML
are gaining increasing interest given their success in
these fields of medicine, where in some cases they are
able to outperform human specialists [3]. The applica-
tion of AI and ML in the orthopedic field is still in an
earlier stage compared to other areas of medicine [1].
Structured research frameworks such as cohort studies
and randomized controlled trials, as well as more experi-
mental research, are still needed for AI and ML to be
widely accepted in orthopedics [1].
ML utilizes computer algorithms and statistics to iden-
tify complex patterns and trends within the data that
otherwise would not be distinguishable by humans [4].
ML can “learn” patterns from data and produce models
linking covariates to a target variable of interest and
build models to describe the behavior of a system [4, 5].
In the field of medicine, ML can compile data from im-
aging and laboratory tests, and electronic medical
records to guide physicians in formulating more effica-
cious and productive decisions [1].
Two broad categories of ML are generally employed in
medicine, depending on the task: supervised learning
and unsupervised learning [5]. Supervised learning fo-
cuses on choosing among subgroups to describe a new
instance of data and estimating an unknown parameter
[5]. For example, an automated interpretation of an elec-
trocardiogram where a specific pattern is linked to a set
of diagnoses, or how a lung nodule from a chest radio-
graph is detected automatically [5]. In contrast, unsuper-
vised learning centers on the patterns or groupings
within the data rather than predicting an output [5]. The
goal of unsupervised learning is to uncover the hidden
structure in the data and learn its pattern [2]. For ex-
ample, endomyocardial biopsies can be taken and histo-
logically examined to identify cellular composition that
can aid in developing targeted therapy for myocarditis
[5]. The category of machine learning applied depends
on the needs of the patient and the physician.
ML holds tremendous potential to improve the quality
of life for patients in a plethora of medical specialties in-
cluding mental health. The Kyoto Prefectural University
of Medicine utilized simple linear regression and L1-
sparse canonical correlation analysis ML algorithms to
identify a clinical biomarker for obsessive-compulsive
disorder (OCD) [6]. Using magnetic resonance imaging
(MRI), the biomarker was able to distinguish between
patients with OCD and non-affected human controls
with 73% accuracy [6]. Repeating the exam with a differ-
ent MRI machine and subset of patients led to 70% ac-
curacy [6]. While only 108 participants took part in this
study, the reproducibility of the data holds promise for
future clinical applications. Furthermore, another study
analyzed tens of thousands of Instagram photos to iden-
tify markers of depression [7]. Researchers utilized color
analysis, Instagram metadata components, and algorithm
face detection to produce predictive models for depres-
sion screening. These predictive models were able to
outperform general practitioners in diagnosing depres-
sion [7]. Results held true even for patients who did not
have an initial diagnosis of depression [7]. The simple
utilization of such ML models in the primary care office
could greatly increase the early and successful diagnosis
of depression.
Radiology is another field which has quickly adopted
ML. In some applications, ML performed as well or even
better than orthopedic surgeons in fracture detection of
the upper limb, ankle, and spine [8]. ML can also be in-
tegrated into current imaging systems making them “in-
telligent,” leading to faster imaging speeds and the
ability to offer modifications to ongoing magnetic reson-
ance imaging sequences to visualize a lesion more accur-
ately [2]. This can also be done by integrating the use of
information from a patient’s medical records, allowing
the program to determine the most appropriate patient-
specific imaging examination and protocol [8]. It even
has the potential to automatically detect incidental find-
ings on imaging and learn how to identify critical find-
ings, such as a pneumothorax [2]. The use of ML does
not aim at replacing the radiologist but augment their
workflow and enhance their diagnostic accuracy [2].
These algorithms are able to identify findings that might
not be so easily seen by the human eye, such as using
the variations in intensity on MRI to predict O6-
methylguanine methyltransferase gene promoter methy-
lation in glioblastoma multiforme tumors [9].
Orthopedic surgery is one of the most technologically
innovative fields in medicine. Nevertheless, AI and ML
adoption is still in a preliminary phase in orthopedics
[1]. ML can be used to provide a patient-specific pre-
dicted rate of post-operative complications, predict
injury risk patterns, and guide clinical decision-making
[8, 10]. Considering the recent growth of ML in the spe-
cialty and the quantity of new research being published,
a systematic review is required. There are over 3300
published articles relating to AI and ML in orthopedics,
with over 1100 of those having been published in the
last 2 years alone. Given the marked increase in the
number of peer-reviewed publications, the primary ob-
jective of this review is to provide an update on the
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advances of AI and ML in the field of orthopedic sur-
gery. The secondary objectives of this review are to
evaluate the applications of AI and ML in providing a
clinical diagnosis and predicting post-operative out-
comes and complications in orthopedic surgery.
Methods
Protocol and registration
The protocol will be registered on the PROSPERO inter-
national prospective register of systematic reviews. The
systematic review will follow the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRIS
MA) statement and guidelines [11, 12].
Eligibility criteria
For the initial literature search, the PICOS (Population,
Intervention, Comparison, Outcome, Study Design)
framework will be utilized for the eligibility criteria [13].
The following characteristics for clinical studies are:
Population
Studies involving human models from adult participants
(18 years or older) will be considered for review, without
any geographical exclusion criteria. Studies meeting eligi-
bility criteria will apply to orthopedic interventions and
acute and chronic orthopedic musculoskeletal injuries. Ar-
ticles will be excluded from eligibility if they are animal
studies or do not relate to orthopedic intervention.
Intervention
The studies considered will present ML models employ-
ing deep learning as an intervention with the aim of pro-
viding diagnosis or clinical prognosis of an orthopedic
surgery intervention. The intervention may be used by
itself or with other methods. Studies will be excluded if
no clinical data were used. Considering that there is no
single best ML model, various models will be used.
Comparison
Gold standard processes and practices to obtain a clin-
ical diagnosis and predict post-operative outcomes shall
be compared with and without the use of ML
algorithms.
Outcomes
The primary outcome is the evaluation of ML models
and how accurately they can provide a clinical diagnosis
and how accurately they can predict post-operative
outcomes and complications of orthopedic surgery
interventions.
Study design
Any case reports and other primary studies assessing the
prediction rate of post-operative outcomes or the ability
to identify a diagnosis in orthopedic surgery will be in-
cluded. Systematic reviews or literature reviews will only
be examined to identify further studies for inclusion,
and the results of the meta-analysis will not be included
in the analysis. Regarding publication year, all studies
published to date will be included.
Information sources
A systematic search will be conducted in PubMed,
ScienceDirect, and Google Scholar databases of English,
Italian, French, Spanish, and Portuguese language arti-
cles published before July 2020. Secondary searching of
reference lists of key articles and reviews will be under-
taken in order to identify any additional studies poten-
tially missed in the electronic search.
Search
The PRISMA checklist and flow diagram will be used as
the eligibility and inclusion criteria during the search
and selection process. A web-based reference software
system (RefWorks) will be used for data management.
Study selection
The study selection process will entail an initial review
by two different reviewers of all titles and abstracts.
These findings will be uploaded to the web-based refer-
ence software system. This will be followed by a second
review, again by two independent reviewers, of the full-
text articles. This will ensure that the remaining articles
meet the inclusion criteria. Discrepancies at any level
will be resolved through discussion with a third
reviewer.
Data collection
Two independent reviewers will perform data extraction
from articles which will meet the inclusion criteria. The
data extracted and synthesized will include study charac-
teristics, application of the ML model, outcome meas-
urement, outcome assessment, and complications or
adverse events reported. Forms will be customized dur-
ing the data extraction and collection process. Primary
authors will be contacted via email if any information re-
quires clarification.
Data items
Relevant items related to study characteristics such as
authors, study design, and year of publication will be ex-
tracted and included. The characteristics of the ML soft-
ware and its specific use in the prediction of a diagnosis
or treatment outcome will also be included. Outcome
measures relating to predicting a diagnosis will include
negative predictive value, positive predictive value, sensi-
tivity, and specificity. Measures extracted and included
for the prediction of post-operative outcomes will
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include function, general outcomes, complications, suc-
cess, and survival.
Risk of bias
Multiple resources will be used to assess the risk of
biases and shall be reported as low risk, moderate risk,
or high risk of biases. Ten domains will be addressed re-
lated to selection bias, performance bias, detection bias,
attrition bias, reporting bias, etc. The Risk Of Bias In
Non-randomized Studies of Interventions (ROBINS-I)
tool assesses observational and quasi-randomized studies
[14]. Seven domains will be used in assessing risk, in-
cluding confounding, participant selection bias, classifi-
cation bias, deviation bias, bias from missing data,
outcome measurement bias, and bias in the selection of
reported results. Studies will be categorized into no in-
formation or a low, moderate, serious, or critical risk of
bias. For randomized control trials, the Risk of Bias 2
(RoB 2) tool will be used to establish the risk of bias
[15]. Five domains of biases will be analyzed, including
those from the randomization process, those arising
from deviations from intended interventions, those from
missing outcome data, those found in measuring the
outcome, and those found in the selection of the re-
ported result. All included studies will be independently
scored by two reviewers, and a discussion will facilitate
consensus of the biases risk levels.
Data synthesis and meta-analysis
Guidelines published by Hooijmans et al. will be used
for the data synthesis and meta-analysis [16]. A random-
effects meta-analysis followed by subgroup analysis will
be performed if appropriate, given the anticipated het-
erogeneity among studies. Sources of potential hetero-
geneity include the ML software used, what it was used
for (diagnosis or treatment), and the treatment popula-
tion and indication. The results of the meta-analysis will
be summarized appropriately with emphasis on design
and outcome measures.
Discussion
Machine learning has incredible potential given its abil-
ity to process large amounts of patient information and
predict patient outcomes, a reason why it is important
for orthopedic surgeons to have the most current infor-
mation. The proposed systematic review will evaluate
the advances of AI and ML in the field of orthopedic
surgery. Given the recent surge in published peer-
reviewed articles in ML and AI in orthopedics, we ex-
pect to identify a large quantity of interesting and rele-
vant yet uncontrolled studies, and a smaller subset of
investigations describing actual applications and out-
comes for clinical care. Research frameworks such as
cohort studies and large randomized control trial will
likely be needed.
Documenting protocol amendments
Protocol amendments and updates will be documented
via PROSPERO online register. The description of the
changes will be recorded, dated, and accessible along
with the most up-to-date version within the record audit
trail under the protocol registration.
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